- Home
- KZIA vs CVR Comparison
KZIA vs CVR Comparison
Compare KZIA & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- CVR
- Stock Information
- Founded
- KZIA 1994
- CVR 1920
- Country
- KZIA Australia
- CVR United States
- Employees
- KZIA N/A
- CVR N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- CVR Industrial Machinery/Components
- Sector
- KZIA Health Care
- CVR Industrials
- Exchange
- KZIA Nasdaq
- CVR Nasdaq
- Market Cap
- KZIA 9.0M
- CVR 9.8M
- IPO Year
- KZIA 1999
- CVR N/A
- Fundamental
- Price
- KZIA $7.20
- CVR $10.15
- Analyst Decision
- KZIA Strong Buy
- CVR
- Analyst Count
- KZIA 3
- CVR 0
- Target Price
- KZIA $16.00
- CVR N/A
- AVG Volume (30 Days)
- KZIA 299.1K
- CVR 2.8K
- Earning Date
- KZIA 11-14-2025
- CVR 11-11-2025
- Dividend Yield
- KZIA N/A
- CVR 1.18%
- EPS Growth
- KZIA N/A
- CVR N/A
- EPS
- KZIA N/A
- CVR N/A
- Revenue
- KZIA $1,549,158.00
- CVR $25,617,681.00
- Revenue This Year
- KZIA N/A
- CVR N/A
- Revenue Next Year
- KZIA $49.25
- CVR N/A
- P/E Ratio
- KZIA N/A
- CVR N/A
- Revenue Growth
- KZIA 248983.08
- CVR N/A
- 52 Week Low
- KZIA $2.86
- CVR $8.15
- 52 Week High
- KZIA $39.05
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- KZIA 43.08
- CVR 45.19
- Support Level
- KZIA $6.20
- CVR $9.52
- Resistance Level
- KZIA $7.61
- CVR $11.08
- Average True Range (ATR)
- KZIA 0.48
- CVR 0.56
- MACD
- KZIA -0.06
- CVR 0.11
- Stochastic Oscillator
- KZIA 47.57
- CVR 55.07
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.